PARES advised the funds Portugal Panorama Capital and Innovation, Research & Creativity on their acquisition and investment in Lxbio Pharmaceuticals

PARES advised the funds Portugal Panorama Capital and Innovation, Research & Creativity, managed by FundBox, on their acquisition and investment in Lxbio Pharmaceuticals.

The team was led by partner Tiago Gama, with the participation of senior associate Duarte Canotilho, from the Financial team, and Pedro Alves Coelho associate, from the Commercial and Corporate team.

The acquisition and investment by funds Portugal Panorama Capital and Innovation, Research & Creativity have the strategic objective of promoting development in priority therapeutic areas, namely severe infections, ophthalmic diseases, and oncology.

We believe this investment will have a direct and transformative impact on health and patients' quality of life, while driving innovation in the pharmaceutical sector.

Read the news published in ADVOCATUS, here (Portuguese version only).